127 related articles for article (PubMed ID: 15997883)
1. Cystic fibrosis genotype and bacterial infection: a possible connection.
McManus TE; Beattie D; Graham C; Moore JE; Elborn JS
Br J Biomed Sci; 2005; 62(2):85-8. PubMed ID: 15997883
[TBL] [Abstract][Full Text] [Related]
2. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
[TBL] [Abstract][Full Text] [Related]
3. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
5. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
Kubesch P; Dörk T; Wulbrand U; Kälin N; Neumann T; Wulf B; Geerlings H; Weissbrodt H; von der Hardt H; Tümmler B
Lancet; 1993 Jan; 341(8839):189-93. PubMed ID: 7678316
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
7. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
8. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients.
Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C
Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous coinfection by multiple strains during Burkholderia cepacia complex infection in cystic fibrosis.
Yang JH; Spilker T; LiPuma JJ
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):95-8. PubMed ID: 16406186
[TBL] [Abstract][Full Text] [Related]
10. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
[TBL] [Abstract][Full Text] [Related]
12. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
[TBL] [Abstract][Full Text] [Related]
13. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.
Tümmler B; Kiewitz C
Mol Med Today; 1999 Aug; 5(8):351-8. PubMed ID: 10431168
[TBL] [Abstract][Full Text] [Related]
15. Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.
Muhdi K; Edenborough FP; Gumery L; O'Hickey S; Smith EG; Smith DL; Stableforth DE
Thorax; 1996 Apr; 51(4):374-7. PubMed ID: 8733488
[TBL] [Abstract][Full Text] [Related]
16. [ANTIBIOTICS SENSITIVITY OF STAPHYLOCOCCUS AUREUS, PSEUDOMONAS AERUGINOSA AND BACTERIA OF BURKHOLDERIA CEPACIA COMPLEX, PERSISTING IN LUNGS OF PATIENTS WITH MUCOVISCIDOSIS (MV)].
Avetisyan LR; Chernukha MY; Shaginyan IA; Kapranov NI; Siyanova EA; Medvedeva OS; Kondratieva EI; Alekseeva GV; Krasovsky SA; Usacheva MV; Amelina EL
Zh Mikrobiol Epidemiol Immunobiol; 2015; (6):3-10. PubMed ID: 26950982
[TBL] [Abstract][Full Text] [Related]
17. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
[TBL] [Abstract][Full Text] [Related]
19. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR
Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301
[TBL] [Abstract][Full Text] [Related]
20. Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex.
Perault AI; Chandler CE; Rasko DA; Ernst RK; Wolfgang MC; Cotter PA
Cell Host Microbe; 2020 Oct; 28(4):534-547.e3. PubMed ID: 32755549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
